论文部分内容阅读
原发性高血压(EH)、动脉粥样硬化(AS)均伴有慢性炎症过程。C反应蛋白(CRP)是高度敏感的炎性因子,其质量浓度测定配合血脂谱可显著提高心血管危险的预测价值。通过中药抗炎干预,降低血清CRP水平,不仅有利于EH的治疗,更有利于控制其并发症,且为抗高血压治疗策略提供了新的思路。
Essential hypertension (EH), atherosclerosis (AS) are associated with chronic inflammatory processes. C-reactive protein (CRP) is a highly sensitive inflammatory factor, and the combination of its concentration with lipid profile can significantly improve the predictive value of cardiovascular risk. Anti-inflammatory intervention by traditional Chinese medicine, lower serum CRP levels, not only conducive to the treatment of EH, more conducive to the control of its complications, and antihypertensive treatment strategies provide a new way of thinking.